Overexpression of HOXB7 raise tamoxifen resistance for early-stage breast cancer pati

[News]

A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.

More... (http://www.news-medical.net/news/20101213/Overexpression-of-HOXB7-raise-tamoxifen-resistance-for-early-stage-breast-cancer-patients.aspx)